Literature DB >> 21706297

Predictive models for worsening prognosis in potential candidates for active surveillance of presumed low-risk prostate cancer.

Prasanna Sooriakumaran1, Abhishek Srivastava, Paul Christos, Sonal Grover, Maria Shevchuk, Ashutosh Tewari.   

Abstract

PURPOSE: Low-risk prostate cancer patients clinically eligible for active surveillance can also be managed surgically. We evaluated the pathologic outcomes for this cohort that was treated by radical prostatectomy and devised nomograms to predict patients at risk of upgrading and/or upstaging.
MATERIALS AND METHODS: Seven hundred and fifty patients treated by radical prostatectomy from Jan 2005 to the present fulfilled conventional active surveillance criteria and formed the study cohort. Preoperative data on standard clinicopathologic parameters were available. The radical prostatectomy specimens were graded and staged, and any upgrading to Gleason sum >6 or upstaging to ≥pT3 ('worsening prognosis') were noted. Multivariable logistic regression models were used to develop predictive nomograms.
RESULTS: Of the 750 patients, 303 (40.4%) patients were either upgraded or upstaged. Multivariable analysis found that preoperative PSA, number of positive cores, and prostate volume were significantly predictive of worsening prognosis and formed the nomogram criteria.
CONCLUSIONS: Of patients deemed eligible for active surveillance based on conventional criteria, 40.4% have worse prognostic factors after radical prostatectomy. Current active surveillance criteria may be too relaxed, and the use of nomograms which we have devised, may aid in counseling primary prostate cancer patients considering active surveillance as their therapy of choice.

Entities:  

Mesh:

Year:  2011        PMID: 21706297      PMCID: PMC3623266          DOI: 10.1007/s11255-011-0020-0

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  28 in total

1.  Interobserver reproducibility of Gleason grading of prostatic carcinoma: urologic pathologists.

Authors:  W C Allsbrook; K A Mangold; M H Johnson; R B Lane; C G Lane; M B Amin; D G Bostwick; P A Humphrey; E C Jones; V E Reuter; W Sakr; I A Sesterhenn; P Troncoso; T M Wheeler; J I Epstein
Journal:  Hum Pathol       Date:  2001-01       Impact factor: 3.466

Review 2.  Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors.

Authors:  F E Harrell; K L Lee; D B Mark
Journal:  Stat Med       Date:  1996-02-28       Impact factor: 2.373

3.  Prostate cancers scored as Gleason 6 on prostate biopsy are frequently Gleason 7 tumors at radical prostatectomy: implication on outcome.

Authors:  Jehonathan H Pinthus; Maciej Witkos; N E Fleshner; Joan Sweet; Andrew Evans; M A Jewett; Murray Krahn; Shabir Alibhai; John Trachtenberg
Journal:  J Urol       Date:  2006-09       Impact factor: 7.450

4.  Extended prostate needle biopsy improves concordance of Gleason grading between prostate needle biopsy and radical prostatectomy.

Authors:  Ignacio F San Francisco; William C DeWolf; Seymour Rosen; Melissa Upton; Aria F Olumi
Journal:  J Urol       Date:  2003-01       Impact factor: 7.450

5.  Discrepancies between Gleason scores of needle biopsy and radical prostatectomy specimens.

Authors:  T Fukagai; T Namiki; H Namiki; R G Carlile; M Shimada; H Yoshida
Journal:  Pathol Int       Date:  2001-05       Impact factor: 2.534

6.  Prostate size and risk of high-grade, advanced prostate cancer and biochemical progression after radical prostatectomy: a search database study.

Authors:  Stephen J Freedland; William B Isaacs; Elizabeth A Platz; Martha K Terris; William J Aronson; Christopher L Amling; Joseph C Presti; Christopher J Kane
Journal:  J Clin Oncol       Date:  2005-10-20       Impact factor: 44.544

7.  Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer.

Authors:  J I Epstein; P C Walsh; M Carmichael; C B Brendler
Journal:  JAMA       Date:  1994-02-02       Impact factor: 56.272

8.  An analysis of men with clinically localized prostate cancer who deferred definitive therapy.

Authors:  Manish I Patel; Dino T DeConcini; Ernesto Lopez-Corona; Makato Ohori; Thomas Wheeler; Peter T Scardino
Journal:  J Urol       Date:  2004-04       Impact factor: 7.450

9.  Cancer statistics, 2009.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2009-05-27       Impact factor: 508.702

10.  Eligibility for active surveillance and pathological outcomes for men undergoing radical prostatectomy in a large, community based cohort.

Authors:  Marc C Smaldone; Janet E Cowan; Peter R Carroll; Benjamin J Davies
Journal:  J Urol       Date:  2010-01       Impact factor: 7.450

View more
  6 in total

1.  Clinical implications of pretreatment inflammatory biomarkers as independent prognostic indicators in prostate cancer.

Authors:  Zhaohui Sun; Ying Ju; Fuyan Han; Xiya Sun; Fang Wang
Journal:  J Clin Lab Anal       Date:  2017-06-12       Impact factor: 2.352

2.  Upgrading and upstaging of low-risk prostate cancer among Korean patients: a multicenter study.

Authors:  Insang Hwang; Donghoon Lim; Young Beom Jeong; Seung Chol Park; Jun Hwa Noh; Dong Deuk Kwon; Taek Won Kang
Journal:  Asian J Androl       Date:  2015 Sep-Oct       Impact factor: 3.285

3.  Low serum total testosterone level as a predictor of upgrading in low-risk prostate cancer patients after radical prostatectomy: A systematic review and meta-analysis.

Authors:  Shu Gan; Jian Liu; Zhiqiang Chen; Songtao Xiang; Chiming Gu; Siyi Li; Shusheng Wang
Journal:  Investig Clin Urol       Date:  2022-05-25

4.  Predicting Low-Risk Prostate Cancer from Transperineal Saturation Biopsies.

Authors:  Pim J van Leeuwen; Amila Siriwardana; Monique Roobol; Francis Ting; Daan Nieboer; James Thompson; Warick Delprado; Anne-Marie Haynes; Phillip Brenner; Phillip Stricker
Journal:  Prostate Cancer       Date:  2016-04-11

5.  Low serum testosterone predicts upgrading and upstaging of prostate cancer after radical prostatectomy.

Authors:  Yuan Gao; Chen-Yi Jiang; Shi-Kui Mao; Di Cui; Kui-Yuan Hao; Wei Zhao; Qi Jiang; Yuan Ruan; Shu-Jie Xia; Bang-Min Han
Journal:  Asian J Androl       Date:  2016 Jul-Aug       Impact factor: 3.285

6.  Low-risk prostate cancer in India: Is active surveillance a valid treatment option?

Authors:  Shanky Singh; Saurabh Patil; Ashwin Sunil Tamhankar; Puneet Ahluwalia; Gagan Gautam
Journal:  Indian J Urol       Date:  2020-07-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.